ATE464912T1 - Wasserlösliche komplexe von arzneistoffen mit hochmolekularen stärkederivaten - Google Patents
Wasserlösliche komplexe von arzneistoffen mit hochmolekularen stärkederivatenInfo
- Publication number
- ATE464912T1 ATE464912T1 AT04735236T AT04735236T ATE464912T1 AT E464912 T1 ATE464912 T1 AT E464912T1 AT 04735236 T AT04735236 T AT 04735236T AT 04735236 T AT04735236 T AT 04735236T AT E464912 T1 ATE464912 T1 AT E464912T1
- Authority
- AT
- Austria
- Prior art keywords
- water
- substance
- high molecular
- complexes
- medicinal
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10324710A DE10324710A1 (de) | 2003-05-30 | 2003-05-30 | Stärkederivatkomplexe |
PCT/EP2004/005801 WO2004105800A2 (de) | 2003-05-30 | 2004-05-28 | Komplexierung von arzneistoffen mit hochmolekularen stärke |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE464912T1 true ATE464912T1 (de) | 2010-05-15 |
Family
ID=33441523
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT04735236T ATE464912T1 (de) | 2003-05-30 | 2004-05-28 | Wasserlösliche komplexe von arzneistoffen mit hochmolekularen stärkederivaten |
Country Status (9)
Country | Link |
---|---|
US (1) | US7932377B2 (de) |
EP (1) | EP1628684B1 (de) |
AT (1) | ATE464912T1 (de) |
DE (2) | DE10324710A1 (de) |
DK (1) | DK1628684T3 (de) |
ES (1) | ES2343066T3 (de) |
PL (1) | PL1628684T3 (de) |
PT (1) | PT1628684E (de) |
WO (1) | WO2004105800A2 (de) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106008746B (zh) * | 2016-05-04 | 2018-11-20 | 青岛大学 | 一种纳塔霉素与o,n-羧甲基壳寡糖的接枝共聚物及其制备方法 |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2661349A (en) * | 1949-02-18 | 1953-12-01 | Nat Starch Products Inc | Polysaccharide derivatives of substituted dicarboxylic acids |
US3455838A (en) * | 1966-04-22 | 1969-07-15 | Nat Starch Chem Corp | Method of encapsulating water-insoluble substances and product thereof |
US3892867A (en) * | 1974-02-07 | 1975-07-01 | Marten Leonard Schoonman | Readily separable instant beverage charge |
US5260050A (en) * | 1988-09-29 | 1993-11-09 | Ranney David F | Methods and compositions for magnetic resonance imaging comprising superparamagnetic ferromagnetically coupled chromium complexes |
DK0543020T3 (da) * | 1991-06-11 | 1998-08-31 | Oxideret sammensætning indeholdende vandopløseligtcarboxypolysaccharid og magnetisk jernoxid | |
MX9206591A (es) * | 1991-11-19 | 1994-05-31 | Nippon Shinyaku Co Ltd | Proceso para la produccion de sacaridos. |
WO1997033552A1 (en) | 1996-03-12 | 1997-09-18 | Pg-Txl Company, L.P. | Water soluble paclitaxel prodrugs |
EP0895784B1 (de) | 1996-04-15 | 2005-11-23 | Asahi Kasei Kabushiki Kaisha | Arzneimittelkomplexe enthaltend taxan-verbindungen oder steroiden |
DE19628705A1 (de) | 1996-07-08 | 1998-01-15 | Fresenius Ag | Neue Sauerstoff-Transport-Mittel, diese enthaltende Hämoglobin-Hydroxyethylstärke-Konjugate, Verfahren zu deren Herstellung, sowie deren Verwendung als Blutersatzstoffe |
US6132787A (en) * | 1997-04-25 | 2000-10-17 | The Procter & Gamble Company | Antimicrobial combinations of a sorbate preservative natamycin and a dialkyl dicarbonate useful in treating beverages and other food products and process of making |
EP2283872A3 (de) * | 1998-04-03 | 2011-02-23 | Mallinckrodt Inc. | Nichtkovalente, zur Diagnose und Therapie nützliche Biokonjugate |
CA2322344A1 (en) | 1999-12-08 | 2001-06-08 | Mallinckrodt Inc. | Non-covalent bioconjugates useful for magnetic resonance imaging |
AU2001266201A1 (en) | 2000-07-01 | 2002-01-14 | M.L. Laboratories Plc | Medicaments |
DE10112825A1 (de) * | 2001-03-16 | 2002-10-02 | Fresenius Kabi De Gmbh | HESylierung von Wirkstoffen in wässriger Lösung |
DE10129369C1 (de) | 2001-06-21 | 2003-03-06 | Fresenius Kabi De Gmbh | Wasserlösliches, einen Aminozucker aufweisendes Antibiotikum in Form eines Pol ysaccharid-Konjugats |
DE10209822A1 (de) | 2002-03-06 | 2003-09-25 | Biotechnologie Ges Mittelhesse | Kopplung niedermolekularer Substanzen an ein modifiziertes Polysaccharid |
-
2003
- 2003-05-30 DE DE10324710A patent/DE10324710A1/de not_active Withdrawn
-
2004
- 2004-05-28 DE DE502004011073T patent/DE502004011073D1/de not_active Expired - Lifetime
- 2004-05-28 DK DK04735236.4T patent/DK1628684T3/da active
- 2004-05-28 US US10/559,005 patent/US7932377B2/en not_active Expired - Fee Related
- 2004-05-28 PT PT04735236T patent/PT1628684E/pt unknown
- 2004-05-28 EP EP04735236A patent/EP1628684B1/de not_active Expired - Lifetime
- 2004-05-28 WO PCT/EP2004/005801 patent/WO2004105800A2/de active Application Filing
- 2004-05-28 PL PL04735236T patent/PL1628684T3/pl unknown
- 2004-05-28 AT AT04735236T patent/ATE464912T1/de active
- 2004-05-28 ES ES04735236T patent/ES2343066T3/es not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
PT1628684E (pt) | 2010-06-23 |
EP1628684B1 (de) | 2010-04-21 |
WO2004105800A2 (de) | 2004-12-09 |
WO2004105800A3 (de) | 2005-02-24 |
ES2343066T3 (es) | 2010-07-22 |
DK1628684T3 (da) | 2010-07-26 |
EP1628684A2 (de) | 2006-03-01 |
US7932377B2 (en) | 2011-04-26 |
US20060183697A1 (en) | 2006-08-17 |
DE502004011073D1 (de) | 2010-06-02 |
PL1628684T3 (pl) | 2010-10-29 |
DE10324710A1 (de) | 2004-12-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1121759T1 (el) | Παραγωγα peg που περιεχουν δυο αλυσιδες peg | |
MX2007005724A (es) | Articulo para tratamiento cosmetico que comprende un sustrato y una composicion en gel. | |
ATE259830T1 (de) | Polymerkomplexe von glukuronoglukanen | |
DE60329839D1 (de) | Behandlung und verhütung von gewebeschäden, die mit erhöhter produktion von c-reactivem protein verbunden sind | |
FI20020195A (fi) | Metallikomplekseja, jotka sisältävät 2,6-diasyylipyridiiniligandin, ja niiden käyttö eteenin polymerointiin | |
DE69623449D1 (de) | Thyroxine/zyklodextrinkomplexe und ihre pharmazeutische formulierung | |
DE60017831D1 (de) | Dermale zusammensetzungen | |
ATE455134T1 (de) | Polymermaterial mit ketten mit imidazolidonfunktionen | |
DE69513395D1 (de) | Zellulare abgabesystem mit cyclodextrin, für oligonukleotiden | |
BRPI0910810A2 (pt) | conjugados derivados de antraciclina, veículo polimérico, anticorpo, peptídeo ou proteína, veículo t-[cho]m, composições farmacêuticas, métodos de tratamento do câncer ou de distúrbios da proliferação celular, derivado de antraciclina, composto conjugado droga-anticorpo, uso, artigo de manufatura e método de produção de um composto conjugado droga-anticorpo" | |
WO2004016801A3 (en) | Cross-linkers with high reactivity and solubility and their use in the preparation of conjugates for targeted delivery of small molecule drugs | |
ATE364654T1 (de) | Polyamideketten von genauer länge und deren konjugate mit proteinen | |
DE69837443D1 (de) | Abbaubare polyethyleneglycolhydrogele mit kontrollierter halbwertzeit und ihre vorprodukte | |
CY1109722T1 (el) | Ενδιαμεσες ενωσεις για την παρασκευη της trans-5-chloro-2-methyl-2,3,3a,12b-tetrahydro-1h-dibenz[2,3:6,73oxepino[4,5-c]pyrrole | |
ATE533784T1 (de) | Lösliche, einzelkettige proteine des t- zellrezeptors | |
EP1551834A4 (de) | Substituierte quinazolinone verbindungen | |
ATE217317T1 (de) | Triazolinthion-phosphorsäure-derivate | |
IT1301994B1 (it) | Derivati dell'acido ialuronico. | |
DE60123225D1 (de) | Clathratekomplexe auf der basis von hyaluronsäurederivaten und deren verwendung als arzneimittel | |
TR200200795T2 (tr) | 5-HT1B antagonistleri olarak piperazin türevleri | |
DE60044030D1 (de) | Markerkomplexe aus konjugierten polymeren | |
BRPI0807981A2 (pt) | Heparinas de baixo peso molecular, compreendendo pelo menos uma ligação covalente com a biotina ou um derivado da biotina, o respectivo processo de preparo e o respectivo uso | |
TR199901949T2 (xx) | Lemfositik t�m�rler i�in �areler. | |
DE60326774D1 (de) | Konjugate von cyanovirin-varianten und einem polyalkylenoxid | |
ATE464912T1 (de) | Wasserlösliche komplexe von arzneistoffen mit hochmolekularen stärkederivaten |